Abstract
Purpose of Review
This review explores the subject of lower urinary tract symptoms (LUTS) in young men.
Recent Findings
Young men (aged 39 or younger) can be affected by a variety of conditions that can cause LUTS. Approximately half of young men report LUTS. Storage or “irritative” voiding symptoms are nearly twice as common as “obstructive” symptoms in young men. Infectious or inflammatory causes such as prostatitis are the most common cause of LUTS in this age group, while other etiologies include urethral strictures, primary bladder neck obstruction, as well as neurogenic and non-neurogenic bladder dysfunction. A thorough clinical evaluation is critical for determining the correct diagnosis and directing the appropriate treatment plan.
Summary
Young men experience lower urinary tract symptoms at relatively high rates. Clinical treatments range from behavioral therapy to medications and/or surgical interventions. Ambulatory urodynamics and wearable sensors may provide more accurate and real-world diagnostic assessment of bladder dysfunction in this relatively under-studied group. More study is needed to characterize the disease burden and impact in this specific group of patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003.
de Groat WC, Yoshimura N. Anatomy and physiology of the lower urinary tract. Handb Clin Neurol. 2015.
Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004.
Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh urology 12th edition. Elsevier. 2015;2.
Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh urology 11th edition. Elsevier. 2015;2.
McAninch JW, Lue TF. Smith & Tanagho’s general urology. McGraw-Hill. 2013.
Kelly CE. Evaluation of voiding dysfunction and measurement of bladder volume. Rev Urol. 2004;6(Suppl):1.
Mangat R, Ho HSS, Kuo TLC. Non-invasive evaluation of lower urinary tract symptoms (LUTS) in men. Asian J Urol. 2018.
Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol. 1998;159.
Digesu GA, Gargasole C, Hendricken C, Gore M, Kocjancic E, Khullar V, et al. ICS teaching module: ambulatory urodynamic monitoring. Neurourol Urodyn. 2017;36.
Kocher NJ, Damaser MS, Gill BC. Advances in ambulatory urodynamics. Curr Urol Rep. 2020.
Burgio KL, Goode PS, Johnson TM, Hammontree L, Ouslander JG, Markland AD, et al. Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial. J Am Geriatr Soc. 2011;59.
Wang AC, Wang YY, Chen MC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology. 2004;63.
Yoshida M, Takeda M, Gotoh M, Nagai S, Kurose T. Vibegron, a novel potent and selective β3-adrenoreceptor agonist, for the treatment of patients with overactive bladder: a randomized, double-blind, placebo-controlled phase 3 study. European Urology. 2018;73.
Nitti VW, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, et al. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013;67.
Finazzi-Agr E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol. 2010;184.
Wazir J, Ullah R, Li S, Hossain MA, Diallo MT, Khan FU, et al. Efficacy of acupuncture in the treatment of chronic prostatitis-chronic pelvic pain syndrome: a review of the literature. Int Urol Nephrol. 2019.
Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4.
Paduch DA. Viral lower urinary tract infections. Curr Urol Rep. 2007.
Pontari MA. Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. 2007.
Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, et al. Comprehensive overview of prostatitis. Biomed Pharmacother. 2017.
•• Bellinato F, Maurelli M, Gisondi P, Lleo’Fernandez MD, Girolomoni G. Clinical profile and co-infections of urethritis in males. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2021. Provides a comprehensive review of prostatitis which represents a spectrum of disease processes with differing management strategies.
Unemo M, Seifert HS, Hook EW, Hawkes S, Ndowa F, Dillon JAR. Gonorrhoea. Nat Rev Dis Primers. 2019;5.
Wessells H, Angermeier KW, Elliott S, Gonzalez CM, Kodama R, Peterson AC, et al. Male urethral stricture: American Urological Association guideline. J Urol. 2017;197.
•• Santucci RA, Joyce GF, Wise M. Male urethral stricture disease. J Urol. 2007;177. AUA guidelines remain one of the best resources for basic diagnosis and management of male urethral stricture disease.
Jarvis TR, Chan L, Tse V. Practical uroflowmetry. BJU International. 2012.
Hughes M, Blakely S, Nikolavsky D. Advancements in transurethral management of urethral stricture disease. Curr Opin Urol. 2021;31.
•• Mann RA, Virasoro R, DeLong JM, Estrella RE, Pichardo M, Lay RR, et al. A drug-coated balloon treatment for urethral stricture disease: two-year results from the ROBUST i study. Can Urol Assoc J. 2020;15. Potential advancements in endoscopic treatment could broaden the role of endoscopic treatment but open repair remains the most durable option in complex cases.
Schifano N, Capogrosso P, Matloob R, Boeri L, Candela L, Fallara G, et al. Patients presenting with lower urinary tract symptoms who most deserve to be investigated for primary bladder neck obstruction. Sci Rep. 2021;11.
Trockman BA, Gerspach J, Dmochowski R, Haab F, Zimmern PE, Leach GE. Primary bladder neck obstruction: urodynamic findings and treatment results in 36 men. J Urol. 1996;156.
Serpilli M, Zitti G, Dellabella M, Castellani D, Maranesi E, Morettini M, et al. A preliminary validation of a new surgical procedure for the treatment of primary bladder neck obstruction using a computational modeling approach. Bioengineering. 2021;8.
Clothier JC, Wright AJ. Dysfunctional voiding: the importance of non-invasive urodynamics in diagnosis and treatment. Pediatr Nephrol. 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
No conflicts of interest for all authors.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction
Rights and permissions
About this article
Cite this article
Beland, L., Martin, C. & Han, J.S. Lower Urinary Tract Symptoms in Young Men—Causes and Management. Curr Urol Rep 23, 29–37 (2022). https://doi.org/10.1007/s11934-022-01087-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-022-01087-9